Obeticholic Acid Patent Expiration

Obeticholic Acid is used for treating Primary Biliary Cholangitis (PBC) in adults. It was first introduced by Intercept Pharmaceuticals Inc in its drug Ocaliva on May 27, 2016. 4 different companies have introduced drugs containing Obeticholic Acid.


Obeticholic Acid Patents

Given below is the list of patents protecting Obeticholic Acid, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ocaliva US10052337 Compositions of obeticholic acid and methods of use Apr 26, 2036 Intercept Pharms Inc
Ocaliva US10751349 Compositions of obeticholic acid and methods of use Apr 26, 2036 Intercept Pharms Inc
Ocaliva US10758549 Compositions of obeticholic acid and methods of use Apr 26, 2036 Intercept Pharms Inc
Ocaliva US10047117 Preparation and uses of obeticholic acid Sep 06, 2033 Intercept Pharms Inc
Ocaliva US10174073 Preparation and uses of obeticholic acid Jun 17, 2033 Intercept Pharms Inc
Ocaliva US9238673 Preparation and uses of obeticholic acid Jun 17, 2033 Intercept Pharms Inc
Ocaliva USRE48286 Steroids as agonists for FXR Feb 21, 2027 Intercept Pharms Inc
Ocaliva US7138390 Steroids as agonists for FXR Nov 16, 2022

(Expired)

Intercept Pharms Inc
Ocaliva US8058267 Steroids as agonists for FXR Feb 21, 2022

(Expired)

Intercept Pharms Inc
Ocaliva US8377916 Steroids as agonists for FXR Feb 21, 2022

(Expired)

Intercept Pharms Inc



Obeticholic Acid's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Obeticholic Acid Generic API Manufacturers

Several generic applications have been filed for Obeticholic Acid. The first generic version for Obeticholic Acid was by Apotex Inc and was approved on May 30, 2023. And the latest generic version is by Msn Laboratories Private Ltd and was approved on May 30, 2023.

Given below is the list of companies who have filed for Obeticholic Acid generic, along with the locations of their manufacturing plants worldwide.


1. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Obeticholic Acid. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A May 30, 2023
10MG

tablet Discontinued ORAL N/A May 30, 2023


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





2. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Obeticholic Acid. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A May 30, 2023
10MG

tablet Discontinued ORAL N/A May 30, 2023


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





3. MSN

Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Obeticholic Acid. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A May 30, 2023
10MG

tablet Discontinued ORAL N/A May 30, 2023


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Kamareddy MSN Life Sciences Private Limited
Sangareddy MSN Pharmachem Private Limited
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Laboratories Private Limited, R&D Center
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Yadadri Bhuvanagiri District MSN Organics Private Limited
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Sangareddy MSN Laboratories Private Ltd.
Isnapur MSN Laboratories Private Limited, Unit-II
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
United States
Piscataway MSN PHARMACEUTICALS INC